JP2007500187A5 - - Google Patents

Download PDF

Info

Publication number
JP2007500187A5
JP2007500187A5 JP2006521802A JP2006521802A JP2007500187A5 JP 2007500187 A5 JP2007500187 A5 JP 2007500187A5 JP 2006521802 A JP2006521802 A JP 2006521802A JP 2006521802 A JP2006521802 A JP 2006521802A JP 2007500187 A5 JP2007500187 A5 JP 2007500187A5
Authority
JP
Japan
Prior art keywords
formula
chloro
compound
alkyl
quinolinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006521802A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007500187A (ja
Filing date
Publication date
Priority claimed from SE0302139A external-priority patent/SE0302139D0/xx
Application filed filed Critical
Publication of JP2007500187A publication Critical patent/JP2007500187A/ja
Publication of JP2007500187A5 publication Critical patent/JP2007500187A5/ja
Withdrawn legal-status Critical Current

Links

JP2006521802A 2003-07-28 2004-07-21 キノリン誘導体および治療におけるその使用 Withdrawn JP2007500187A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0302139A SE0302139D0 (sv) 2003-07-28 2003-07-28 Novel compounds
PCT/SE2004/001144 WO2005009968A1 (en) 2003-07-28 2004-07-21 Quinoline derivates and their use in therapy

Publications (2)

Publication Number Publication Date
JP2007500187A JP2007500187A (ja) 2007-01-11
JP2007500187A5 true JP2007500187A5 (cg-RX-API-DMAC7.html) 2007-07-26

Family

ID=27786663

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006521802A Withdrawn JP2007500187A (ja) 2003-07-28 2004-07-21 キノリン誘導体および治療におけるその使用

Country Status (16)

Country Link
US (1) US20080058293A1 (cg-RX-API-DMAC7.html)
EP (1) EP1651610A1 (cg-RX-API-DMAC7.html)
JP (1) JP2007500187A (cg-RX-API-DMAC7.html)
KR (1) KR20060054370A (cg-RX-API-DMAC7.html)
CN (1) CN1829694A (cg-RX-API-DMAC7.html)
AU (1) AU2004259615A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0413094A (cg-RX-API-DMAC7.html)
CA (1) CA2532154A1 (cg-RX-API-DMAC7.html)
CO (1) CO5640110A2 (cg-RX-API-DMAC7.html)
IL (1) IL172826A0 (cg-RX-API-DMAC7.html)
IS (1) IS8329A (cg-RX-API-DMAC7.html)
MX (1) MXPA06000882A (cg-RX-API-DMAC7.html)
RU (1) RU2006102127A (cg-RX-API-DMAC7.html)
SE (1) SE0302139D0 (cg-RX-API-DMAC7.html)
WO (1) WO2005009968A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200600820B (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0312609D0 (en) 2003-06-02 2003-07-09 Astrazeneca Ab Novel compounds
WO2006110516A1 (en) * 2005-04-11 2006-10-19 Abbott Laboratories Acylhydrazide p2x7 antagonists and uses thereof
ES2596532T3 (es) 2006-03-16 2017-01-10 Second Genome, Inc. Compuestos de bicicloheteroarilo como moduladores de P2X7 y usos de los mismos
CA2645556C (en) 2006-03-16 2016-05-24 Renovis, Inc. Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2008013494A1 (en) * 2006-07-27 2008-01-31 Astrazeneca Ab Quinoline derivatives as p2x7 receptor antagonist and their use in the treatment of rheumatoid arthritis, osteoarthritis, copd and ibd
RU2460727C2 (ru) * 2007-03-22 2012-09-10 Астразенека Аб Хинолиновые производные для лечения воспалительных заболеваний
PE20091036A1 (es) * 2007-11-30 2009-08-15 Astrazeneca Ab Derivado de quinolina como antagonista del receptor p2x7
AU2009228649B2 (en) 2008-03-25 2014-05-22 Affectis Pharmaceuticals Ag Novel P2X7R antagonists and their use
DK2243772T3 (da) 2009-04-14 2012-02-13 Affectis Pharmaceuticals Ag Hidtil ukendte P2X7R-antagonister og deres anvendelse
AU2010340142B2 (en) * 2009-12-17 2014-05-08 Merck Sharp & Dohme Corp. Quinoline amide M1 receptor positive allosteric modulators
EP2386541A1 (en) 2010-05-14 2011-11-16 Affectis Pharmaceuticals AG Novel methods for the preparation of P2X7R antagonists
WO2012110190A1 (en) 2011-02-17 2012-08-23 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
WO2012163456A1 (en) 2011-05-27 2012-12-06 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
WO2012163792A1 (en) 2011-05-27 2012-12-06 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
MX2014000894A (es) 2011-07-22 2014-02-27 Actelion Pharmaceuticals Ltd Derivados de amidas heterociclicas como antagonistas de receptores p2x7.
TWI576347B (zh) 2012-01-20 2017-04-01 艾克泰聯製藥有限公司 作為p2x受體拮抗劑之雜環醯胺衍生物
KR102232742B1 (ko) 2012-12-12 2021-03-26 이도르시아 파마슈티컬스 리미티드 P2x7 수용체 길항제로서의 인돌 카르복사미드 유도체
WO2014097140A1 (en) 2012-12-18 2014-06-26 Actelion Pharmaceuticals Ltd Indole carboxamide derivatives as p2x7 receptor antagonists
JP6282016B2 (ja) 2013-01-22 2018-02-21 イドーシア ファーマシューティカルズ リミテッドIdorsia Pharmaceuticals Ltd P2x7受容体アンタゴニストとしての複素環アミド誘導体
JP6282017B2 (ja) 2013-01-22 2018-02-21 イドーシア ファーマシューティカルズ リミテッドIdorsia Pharmaceuticals Ltd P2x7受容体アンタゴニストとしての複素環アミド誘導体
JP6692759B2 (ja) * 2014-06-05 2020-05-13 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung 新規キノリン誘導体及び神経変性疾患におけるそれらの使用
AU2018235561B2 (en) * 2017-03-13 2020-06-18 Asahi Kasei Pharma Corporation Tetrahydroquinoline derivatives as P2X7 receptor antagonists
CN111777638B (zh) * 2020-05-22 2023-05-09 瀚海新拓(杭州)生物医药有限公司 喹啉类化合物、其制备方法、药物组合物和用途
CN114989082B (zh) * 2022-06-30 2024-06-21 华东理工大学 基于i价铜化物和三取代膦协同催化的羟氯喹的高效制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3471491A (en) * 1967-08-28 1969-10-07 Squibb & Sons Inc Adamantyl-s-triazines
US3464998A (en) * 1968-03-04 1969-09-02 Searle & Co Adamantyl esters and amides of pyridinecarboxylic acids
US4751292A (en) * 1985-07-02 1988-06-14 The Plant Cell Research Institute, Inc. Adamantyl purines
DK0501656T3 (da) * 1991-02-21 1997-07-21 Sankyo Co Benzenderivater med en fremskyndende aktivitet på produktion af nervevækstfaktor
DE69531458T2 (de) * 1994-05-27 2004-08-05 Glaxosmithkline S.P.A. Chinolinderivate als tachykinin nk3 rezeptor antagonisten
AR004735A1 (es) * 1995-11-24 1999-03-10 Smithkline Beecham Spa Quinoleina 4-amido sustituida, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso de los mismos para lapreparacion de un medicamento.
NZ332341A (en) * 1996-05-20 2000-05-26 Darwin Discovery Ltd Quinoline carboxamides as TNF inhibitors and as PDE-IV inhibitors
GB0013737D0 (en) * 2000-06-07 2000-07-26 Astrazeneca Ab Novel compounds
CA2452606C (en) * 2001-07-02 2011-09-13 Akzo Nobel N.V. Tetrahydroquinoline derivatives
SE0103836D0 (sv) * 2001-11-16 2001-11-16 Astrazeneca Ab Novel compounds

Similar Documents

Publication Publication Date Title
TWI843372B (zh) 用於降解突變kras蛋白之化合物及其應用
JP2006526617A5 (cg-RX-API-DMAC7.html)
ES2626390T3 (es) Moduladores del receptor gamma huérfano relacionado con retinoide (ROR-gamma) para uso en el tratamiento de enfermedades autoinmunitarias e inflamatorias
JP5580741B2 (ja) 含窒素複素環化合物およびその用途
RU2006102127A (ru) Производные хинолина и их применение в терапии
JP5965909B2 (ja) 選択的アンドロゲン受容体モジュレーター
JP4335212B2 (ja) インダゾール誘導体
ES2791340T3 (es) Derivado de urea o sal farmacológicamente aceptable del mismo
US20050124577A1 (en) 8-Azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
RU2005136130A (ru) Новые антагонисты р2х7 рецепторов и их применение
RU2569887C2 (ru) Производные оксазолинов для лечения расстройств цнс
JPH10506399A (ja) 1−アシル−4−マリファチルアミノピペリジン化合物
JP2005509003A5 (cg-RX-API-DMAC7.html)
CN1360591A (zh) 具有麻醉剂活性的3α-羟基-3β-甲氧基甲基-21-杂环取代的类固醇
PT1680418E (pt) Derivados de n-[heteroaril ( piperidin-2-il)-metil] benzamida, sua preparação e sua aplicação em terapêutica
CA2466965A1 (en) Sulphonamide derivatives, their preparation and use as medicaments
RU2637938C2 (ru) Производные триазолкарбоксамида
JP6032451B2 (ja) 新規なレバミピド前駆体及びその製造方法と用途
BRPI0708490B1 (pt) Composto, composição farmacêutica, processo para preparar um composto da fórmula (I), e uso de um composto
BR112015004511B1 (pt) Derivados de pirazol carboxamida como moduladores de taar para uso no tratamento de diversas desordens, tais como depressão, diabetes e doença de parkinson
CN1326853C (zh) 4-(2-呋喃甲酰)氨基哌啶、其合成中间体、其制备方法及其作为药物的用途
EP3186224A1 (en) Substituted azetidine derivatives as taar ligands
JP2005272321A (ja) 含窒素複素環化合物およびその医薬用途
BE1009571A3 (fr) Nouveaux derives de piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant.
ES2414159T3 (es) Antagonistas de acrilamida piperidilo de CCR2